相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells
Maira M. Pires et al.
CANCER BIOLOGY & THERAPY (2013)
An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo
Pradip De et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC
Ranjan Preet et al.
CARCINOGENESIS (2013)
Understanding the biology of triple-negative breast cancer
C. Criscitiello et al.
ANNALS OF ONCOLOGY (2012)
PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers
Roy R. L. Bastien et al.
BMC MEDICAL GENOMICS (2012)
Dissecting the Heterogeneity of Triple-Negative Breast Cancer
Otto Metzger-Filho et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Expression of Wnt3 Activates Wnt/β-Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells
Yanyuan Wu et al.
MOLECULAR CANCER RESEARCH (2012)
Inhibition of Tankyrases Induces Axin Stabilization and Blocks Wnt Signalling in Breast Cancer Cells
Renyue Bao et al.
PLOS ONE (2012)
Evolutionary Pathways in BRCA1-Associated Breast Tumors
Filipe C. Martins et al.
CANCER DISCOVERY (2012)
Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform
M. Abramovitz et al.
BRITISH JOURNAL OF CANCER (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation
Felipe C. Geyer et al.
MODERN PATHOLOGY (2011)
Directed Therapy of Subtypes of Triple-Negative Breast Cancer
Lisa A. Carey
ONCOLOGIST (2011)
Molecular Stratification of Triple-Negative Breast Cancers
Charles M. Perou
ONCOLOGIST (2011)
Triple-Negative Breast Cancer A Short Review
Anthony D. Elias
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2010)
Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
Andrey I. Khramtsov et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Health disparities in breast cancer: biology meets socioeconomic status
Barbara K. Dunn et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Cytoplasmic Localization of beta-Catenin is a Marker of Poor Outcome in Breast Cancer Patients
Elena Lopez-Knowles et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Does the PI3K Pathway Play a Role in Basal Breast Cancer?
Stacy L. Moulder
CLINICAL BREAST CANCER (2010)
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
B. Corkery et al.
ANNALS OF ONCOLOGY (2009)
In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models
Klaus P. Hoeflich et al.
CLINICAL CANCER RESEARCH (2009)
Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer
Y. J. Fang et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer
Dezheng Huo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
Jessica Kao et al.
PLOS ONE (2009)
Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay
Mark Abramovitz et al.
BIOTECHNIQUES (2008)
Association of genetic variation in genes implicated in the β-catenin destruction complex with risk of breast cancer
Xianshu Wang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Common MMP-7 polymorphisms and breast cancer susceptibility:: A multistage study of association and functionality
Alicia Beeghly-Fadiel et al.
CANCER RESEARCH (2008)
Beyond cytotoxic chemotherapy for the first-line treatment of HER2-negative, hormone-insensitive metastatic breast cancer: Current status and future opportunities
Alison K. Conlin et al.
CLINICAL BREAST CANCER (2008)
Development of therapeutic approaches to 'triple negative' phenotype breast cancer
Kai-Keen Shiu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Corretation between β-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors
Hiroshi Matono et al.
HUMAN PATHOLOGY (2008)
Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/β-catenin signaling pathway in hepatocellular carcinoma cells
Miran Kim et al.
JOURNAL OF HEPATOLOGY (2008)
Progress and promise:: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2007)
CSK controls retinoic acid receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiation
Nandini Dey et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
Thomas Schlange et al.
BREAST CANCER RESEARCH (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Absolute β-catenin concentrations in Wnt pathway-stimulated and non-stimulated cells
S. Sievers et al.
BIOMARKERS (2006)
Wnt signaling pathway in mammary gland development and carcinogenesis
Gulisa Turashvili et al.
PATHOBIOLOGY (2006)
Targeting matrilysin and its impact on tumor growth in vivo:: The potential implications in breast cancer therapy
WG Jiang et al.
CLINICAL CANCER RESEARCH (2005)
CSK negatively regulates nerve growth factor induced neural differentiation and augments AKT kinase activity
N Dey et al.
EXPERIMENTAL CELL RESEARCH (2005)
Upregulation of TCF4 expression as a transcriptional target of β-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells
M Saegusa et al.
LABORATORY INVESTIGATION (2005)
Relevance of breast cancer cell lines as models for breast tumours: an update
M Lacroix et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma
HC Zheng et al.
PATHOLOGY INTERNATIONAL (2003)
PTEN: a new twist on beta-catenin?
V Stambolic
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
β-catenin, a novel prognostic marker for breast cancer:: Its roles in cyclin D1 expression and cancer progression
SY Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer
M Jonsson et al.
EUROPEAN JOURNAL OF CANCER (2000)
分享论文
